Penbraya Kit
Product Images NDC 0069-0600
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Penbraya (NDC 0069-0600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Syringe (Penbraya 02)
Luer lock adapter is a commonly used medical device accessory. It is designed to securely connect different medical equipment or devices together. The adapter features a male Luer lock connector on one end and a female Luer lock connector on the other end. This allows for a reliable and leak-free connection between various medical components, such as syringes, catheters, and IV lines. The Luer lock mechanism ensures that the connection remains secure during medical procedures, preventing accidental disconnections and minimizing the risk of contamination. Overall, the Luer lock adapter is an essential tool in medical settings for ensuring safe and efficient medical equipment connections.*
Vial Adapter (Penbraya 03)
Step 1 (Penbraya 04)
Step 2 (Penbraya 05)
Step 3 (Penbraya 06)
Step 4 (Penbraya 07)
Step 5 (Penbraya 08)
Step 6 (Penbraya 09)
Step 7 (Penbraya 10)
Step 8 (Penbraya 11)
Step 9 (Penbraya 12)
Step 10 (Penbraya 13)
Logo (Penbraya 14)
Principal Display Panel (1 Vial/Syringe Kit Carton)
Principal Display Panel (5 Vial/Syringe Kit Carton)
Principal Display Panel (10 Vial/Syringe Kit Carton)
Principal Display Panel (1 Vial Label)
This text appears to be a description of a lyophilized (freeze-dried) component with the National Drug Code (NDC) 0069-0271-01. It is specifically mentioned that this MenACWY Component should not be used alone and should be reconstituted with the MenB Component to form a Meningococcal Group A, B, C, W, and Y Vaccine called PENBRAYA™. The recommended dose after reconstitution is approximately 0.5 mL. The text ends with the code PAA212956.*
Principal Display Panel (1 Syringe Label)
This text appears to be a description of a vaccine called "PENBRAYA™" manufactured by Pfizer Ireland. It is a combination of two components: MenB and MenACWY. The vaccine is used to prevent meningococcal infections caused by groups A, B, C, W, and Y. The text also mentions that the MenB component should not be used alone and needs to be mixed with the Lyophilized MenACWY component before administration. It provides a lot number and expiration date, indicating the batch information for the product. Additionally, it instructs to shake the mixture well before use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.